Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on February 05, 2016, to consider & approve the un-audited financial results for the quarter/ nine months ended December 31, 2015 (Q3). Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from January 25, 2016 to February 07, 2016 for all the connected persons.
The above information is a part of company’s filings submitted to BSE.